Milan, Italy

Pier Paolo Di Fiore

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pier Paolo Di Fiore in Breast Cancer Research

Introduction

Pier Paolo Di Fiore, based in Milan, Italy, is a distinguished inventor known for his significant contributions to breast cancer research. With a total of four patents to his name, Di Fiore is pioneering advancements that enhance the understanding and treatment of this prevalent disease.

Latest Patents

Among his most recent innovations are patents focused on methods and kits comprising gene signatures for stratifying breast cancer patients. These inventions relate to refined prognostic clinical tools, methods, and kits aimed at evaluating the risk and treatment of distant recurrence specifically in ER+/HER2− breast cancer patients. Di Fiore's work is crucial in offering personalized medicine approaches for better patient outcomes.

Career Highlights

Pier Paolo Di Fiore has been affiliated with renowned institutions throughout his career, including the IFOM (Fondazione Instituto FIRC di Oncologia Molecolare) and Istituto Europeo di Oncologia S.r.l. His work at these leading research centers has positioned him as a key figure in cancer biology and treatment innovations.

Collaborations

Throughout his career, Di Fiore has collaborated with prominent researchers such as Salvatore Pece and Manuela Vecchi. These collaborations not only enhance the quality of his research but also foster a multidisciplinary approach to tackling complex problems in oncology.

Conclusion

Pier Paolo Di Fiore is a remarkable inventor whose work has significantly impacted breast cancer treatment strategies. Through his innovative patents and collaborations in top research institutions, he continues to push the boundaries of medical research, paving the way for future advancements in personalized cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…